Y-Intercept (HK)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-9,251
| Closed | -$1.94M | – | 1589 |
|
2025
Q1 | $1.94M | Buy |
9,251
+4,322
| +88% | +$906K | 0.13% | 194 |
|
2024
Q4 | $876K | Buy |
+4,929
| New | +$876K | 0.06% | 479 |
|
2024
Q3 | – | Sell |
-12,505
| Closed | -$2.14M | – | 1240 |
|
2024
Q2 | $2.14M | Buy |
+12,505
| New | +$2.14M | 0.12% | 231 |
|
2024
Q1 | – | Sell |
-6,943
| Closed | -$1.08M | – | 1314 |
|
2023
Q4 | $1.08M | Buy |
+6,943
| New | +$1.08M | 0.1% | 294 |
|
2023
Q3 | – | Sell |
-33,789
| Closed | -$4.55M | – | 1002 |
|
2023
Q2 | $4.55M | Buy |
+33,789
| New | +$4.55M | 0.48% | 11 |
|
2022
Q4 | – | Sell |
-10,765
| Closed | -$1.44M | – | 947 |
|
2022
Q3 | $1.44M | Buy |
+10,765
| New | +$1.44M | 0.14% | 211 |
|
2021
Q3 | – | Sell |
-3,843
| Closed | -$433K | – | 616 |
|
2021
Q2 | $433K | Buy |
3,843
+1,284
| +50% | +$145K | 0.11% | 299 |
|
2021
Q1 | $273K | Buy |
+2,559
| New | +$273K | 0.07% | 443 |
|